Dr. Bunker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Friendship Ave
Allegheny Pathology Associates
Pittsburgh, PA 15224Phone+1 412-578-7120Fax+1 412-578-4526
Education & Training
- UPMC Medical Education/Presbyterian Shadyside HospitalResidency, Immunopathology, 1988 - 1990
- UPMC Medical EducationResidency, Pathology-Anatomic and Clinical, 1986 - 1988
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Pathology-Anatomic and Clinical, 1984 - 1986
- Queen's University of Belfast COMClass of 1983
Certifications & Licensure
- PA State Medical License 1985 - 2024
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
- American Board of Pathology Immunopathology
Clinical Trials
- Treatment-Resistant Depression Registry Start of enrollment: 2006 Jan 01
- Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 24 citationsExpression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma.Yulin Liu, Charles D. Sturgis, Mark Bunker, Reda S. Saad, Ming Tung
Modern Pathology. 2004-09-01 - 19 citationsGrb7 Expression and Correlation With her2 Amplification in Invasive Breast CarcinomaWilliam W. Bivin, Oleksandr Yergiyev, Mark Bunker, Jan F. Silverman, Uma Krishnamurti
Applied Immunohistochemistry & Molecular Morphology. 2017-09-01 - 4 citationsPrimary renal carcinoid tumour with lung metastasis misdiagnosed as renal cell carcinoma.Nour Daboul, Dulabh Monga, Mark Bunker
BMJ Case Reports. 2016-03-07
Press Mentions
- A Great Masquerader: Nasal Type, Extranodal Natural Killer/T-cell Lymphoma Presenting as Recalcitrant Bacterial Sinusitis and Periorbital CellulitisDecember 16th, 2020
- A Great Masquerader: Nasal Type, Extranodal Natural Killer/T-cell Lymphoma Presenting as Recalcitrant Bacterial Sinusitis and Periorbital CellulitisDecember 15th, 2020
- The Assessment of Resistance to Antidepressant Treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF)March 22nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: